Nociceptin/orphanin FQ metabolism: Role of aminopeptidase and endopeptidase 24.15

Journal of Neurochemistry

Volumn 68, Issue 1, 1997, Pages 354-361

  Montiel, Jose Luis ^a   Cornille, Fabrice ^a   Roques, Bernard P ^a,b   Noble, Florence ^a  

^a Laboratoire de Pharmacochimie   (France)

^b CNRS   (France)

Author keywords

Aminopeptidase N; Brain slices; Endopeptidase 24.15; Enkephalin; Metabolism; Nociceptin orphanin FQ

Indexed keywords

AMINOPEPTIDASE; ENDORPHIN; PROTEINASE;

ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; BRAIN REGION; DRUG RECEPTOR BINDING; ENZYME ACTIVITY; MOUSE; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL;

ANIMALIA;

EID: 0031037197     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1997.68010354.x     Document Type: Article

References (53)

1. 8. J. Neurochem. 48, 284-292.
2. Barnes K., Doherty S., and Turner A. J. (1995) Endopeptidase-24.11 is the integral membrane peptidase initiating degradation of somatostatin in the hippocampus. J. Neurochem. 64, 1826-1832.
3. Beaumont A., Barbe B., Le Moual H., Boileau G., Crine P., Fournié-Zaluski M. C., and Roques B. P. (1992) Charge polarity reversal inverses the specificity of neutral endopeptidase-24.11. J. Biol. Chem. 267, 2138-2141.
4. Bunzow J. R., Saez C., Mortrud M., Bouvier C., Williams J. T., Low M., and Grandy D. K. (1994) Molecular cloning and tissue distribution of a putative member of the rat opioid receptor gene family that is not a μ δ or κ opioid receptor type. FEBS Lett. 347, 284-288.
5. Checler F., Barelli H., Kitabgi P., and Vincent J.-P. (1988) Neurotensin metabolism in various tissues of central and peripheral origins: ubiquitous involvement of a novel neurotensin degrading metalloendopeptidase. Biochimie 70, 75-82.
6. Chen Y., Fan Y., Liu J., Mestek A., Tian M., Kozak C. A., and Yu L. (1994) Molecular cloning, tissue distribution and chromosomal localization of a novel member of the opioid receptor gene family. FEBS Lett. 347, 279-283.
7. Churchill L., Bausback H. H., Gerritsen M. E., and Ward P. E. (1987) Metabolism of opioid peptides by cerebral microvascular aminopeptidase M. Biochim. Biophys. Acta 923, 35-41.
8. Csuhai E., Safavi A., and Hersh L. B. (1995) Purification and characterization of a secreted arginine-specific dibasic cleaving enzyme from the EL-4 cells. Biochemistry 34, 12411-12419.
9. Deschodt-Lanckman M. and Bui N. D. (1981) Cholecystokinin octaand tetrapeptide degradation by synaptic membranes. I. Evidence for competition with enkephalins for in vitro common degradation pathways. Peptides 2 (Suppl. 2), 113-118.
10. 8 analogues by rat brain slices. Neuropeptides 7, 1-9.
11. Fournié-Zaluski M. C., Perdrisot R., Gacel G., Swerts J. P., Roques B. P., and Schwartz J. C. (1979) Inhibitory potency of various peptides on enkephalinase activity from mouse striatum. Biochem. Biophys. Res. Commun. 91, 130-135.
12. Fournié-Zaluski M. C., Coric P., Turcaud S., Bruetschy L., Noble F., and Roques B. P. (1992) Potent and systemically active aminopeptidase N inhibitors designed from active-site investigation. J. Med. Chem. 35, 1259-1266.
13. Fukuda K., Kato S., Mori K., Nishi M., Takeshima H., Iwabe N., Miyata T., Houtani T., and Sugimoto T. (1994) cDNA cloning and regional distibution of a novel member of the opioid receptor family. FEBS Lett. 343, 42-46.
14. Habgood N., Eastman H., and Turner A. J. (1994) Molecular cloning of endopeptidase 24.15 from pig brain. (Abstr.) Biochem. Soc. Trans. 22, 415S.
15. Hernandez J. F., Soleilhac J. M., Roques B. P., and Fournié-Zaluski M. C. (1988) Retro-inverso concept applied to the mixed inhibitors of enkephalin-degrading enzymes. J. Med. Chem. 31, 1825-1831.
16. Houtani T., Nishi M., Takeshima H., Nukuda T., and Sugimoto T. (1996) Structure and regional distribution of nociceptin/ orphanin FQ precursor. Biochem. Biophys. Res. Commun. 219, 714-719.
17. Jiracek J., Yiotakis A., Vincent B., Lecoq A., Nicolaou A., Checler F., and Dive V. (1995) Development of highly potent and selective phosphinic peptide inhibitors of zinc endopeptidase 24-15 using combinatory chemistry. J. Biol. Chem. 270, 21701-21706.
18. Kawabata S.-I., Nakagawa K., Muta T., Iwagata S., and Davie E. W. (1993) Rabbit liver microsomal endopeptidase with substrate specificity for processing proproteins is structurally related to rat testes metalloendopeptidase 24.15. J. Biol. Chem. 268, 12498-12503.
19. Kenny A. J., Stephenson S. L., and Turner A. J. (1987) Cell surface peptidases, in Mammalian Ectoenzymes (Kenny A. J. and Turner A. J., eds), pp. 169-210. Elsevier Science Publisher, Amsterdam.
20. Kest B., Orlowski M., Molineaux C. J., and Bodnar R. J. (1991) Antinociceptive properties of inhibitors of endopeptidase 24.15. Int. J. Neurosci. 56, 141-149.
21. Lachowicz J. E., Shen Y., Monsma F. G. Jr., and Sibley D. R. (1995) Molecular cloning of a novel G protein-coupled receptor related to the opiate receptor family. J. Neurochem. 64, 34-40.
22. Lucius R., Sievers J., and Mentlein R. (1995) Enkephalin metabolism by microglia aminopeptidase N (CD13). J. Neurochem. 64, 1841-1847.
23. Malfroy B., Swerts J. P., Guyon A., Roques B. P., and Schwartz J.C. (1978) High-affinity enkephalin-degrading peptidase in mouse brain and its enhanced activity following morphine. Nature 276, 523-526.
24. McDonald J. K. and Barren A. J. (1986) Mammalian proteases, in A Glossary and Bibliography, Vol. 2: Exopeptidases. Academic Press, London.
25. Mentlein R. and Dahms P. (1994) Endopeptidase 24.16 and 24.15 are responsible for the degradation of somatostatin, neurotensin, and other neuropeptides by cultivated rat cortical astrocytes. J. Neurochem. 62, 27-36.
26. Merrifield R. B. (1963) Solid phase peptide synthesis. I. The synthesis of a tetrapeptide. J. Am. Chem. Soc. 85, 2149-2154.
27. Meunier J. C., Mollereau C., Toll L., Suaudeau C., Moisand C., Alvinerie P., Butour J. L., Guillemot J. C., Ferrara P., Monsarrat B., Mazarguil H., Vassart G., Parmentier M., and Costentin J. (1995) Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature 377, 532-535.
28. Molineaux C. J., Yu B., and Ayala J. M. (1990) An inhibitor of endopeptidase-24.15 blocks the degradation of intraventricularly administered dynorphins. J. Neurochem. 55, 611-618.
29. Mollereau C., Parmentier M., Mailleux P., Butour J. L., Moisand C., Chalon P., Caput D., Vassart G., and Meunier J. C. (1994) ORL1, a novel member of the opioid receptor family. Cloning, functional expression and localization. FEBS Lett. 341, 33-38.
30. Olsen J., Corvell G. M., Konigshofer F. G., Danielsen E. M., Moller J., Laustsen L., Hausen O. C., Welinder F. G., Engberg J., Hunziber W., Spiers M., Sjostrom H., and Noren O. (1988) Complete amino acid sequence of human intestinal aminopeptidase N as deduced from cloned cDNA. FEBS Lett. 238, 307-314.
31. Orlowski M., Michaud C., and Chu T. G. (1983) A soluble metallopeptidase from rat brain. Purification of the enzyme and determination of specificity with synthetic and natural peptides. Eur. J. Biochem. 135, 81-88.
32. Paxinos G. and Watson C. (1986) The Rat Brain in Stereotaxic Coordinates, 2nd edit. Academic Press, New York.
33. Pierotti A., Dong K. W., Glucksman M. J., Orlowski M., and Roberts J. L. (1990) Molecular cloning and primary structure of rat testes metallopeptidase EC 3.4.24.15. Biochemistry 29, 10323-10329.
34. Reinscheid R. K., Nothacker H. P., Bourson A., Ardati A., Henningsen R. A., Bunzow J. R., Grandy D. K., Langen H., Monsma F. J. Jr., and Civelli O. (1995) Orphanin FQ: a neuropeptide that activates an opioid like G protein-coupled receptor. Science 270, 792-794.
35. Reisine T. (1995) Opiate receptors. Neuropharmacology 34, 463-472.
36. Roques B. P. (1988) Physiological role of endogenous peptide effectors studied with peptidase inhibitors. Kidney Int. 34 (Suppl.), S27-S33.
37. Roques B. P. and Fournié-Zaluski M. C. (1986) Enkephalin degrading enzyme inhibitors: a physiological way to new analgesics and psychoactive agents. Natl. Inst. Drug Abuse Res. Monogr. Ser. 70, 128-154.
38. Roques B. P., Lucas-Soroca E., Chaillet P., Costentin J., and Fournié-Zaluski M. C. (1983) Complete differentiation between "enkephalinase" and angiotensin converting enzyme inhibition by retro-thiorphan. Proc. Natl. Acad. Sci. USA 80, 3178-3182.
39. Roques B. P., Noble F., Daugé V., Fournié-Zaluski M. C., and Beaumont A. (1993) Neutral endopeptidase 24.11: structure, inhibition, and experimental and clinical pharmacology. Pharmacol. Rev. 45, 87-146.
40. Safavi A. and Hersh L. B. (1995) Degradation of dynorphin-related peptides by the puromycin-sensitive aminopeptidase and amino-peptidase M. J. Neurochem. 65, 389-395.
41. Turner A. J., Hooper N. M., and Kenny A. J. (1987) Metabolism of neuropeptides, in Mammalian Ectoenzymes (Kenny A. J. and Turner A. J., eds), pp. 211-248. Elsevier Science Publisher, Amsterdam.
42. Umezawa H., Adyagi T., Suda H., Hamada M., and Takeuchi T. (1976) Bestatin, an inhibitor of aminopeptidase B produced by Actinomvcetes. J. Antibiol. (Tokyo) 29, 96-99.
43. Vaughan C. W. and Christie M. J. (1996) Increase by the ORL1 receptor (opioid receptor-like 1) ligand, nociceptin, of inwardly rectifying K conductance in dorsal raphe nucleus neurons. Br. J. Pharmacol. 117, 1609-1611.
44. Vincent B., Dive V., Yiotakis A., Smadja C., Maldonado R., Vincent J.-P., and Checler F. (1995) Phosphorus-containing peptides as mixed inhibitors of endopeptidase 3.4.24.15 and 3.4.24.16: effect on neurotensin degradation in vitro and in vivo. Br. J. Pharmacol. 115, 1053-1063.
45. Waksman G., Bouboutou R., Devin J., Bourgoin S., Cesselin F., Hamon M., Fournié-Zaluski M. C., and Roques B. P. (1985) In vitro and in vivo effects of kelatorphan on enkephalin metabolism in rodent brain. Eur. J. Pharmacol. 117, 233-243.
46. Waksman G., Hamel E., Fournié-Zaluski M. C., and Roques B. P. (1986) Autoradiographic comparison of the distribution of the neutral endopeptidase "enkephalinase" and of mu and delta opioid receptors in rat brain. Proc. Natl. Acad. Sci. USA 83, 1523-1527.
47. Wang J. B., Johnson P. S., Imai Y., Persico A. M., Ozenberger B. A., Eppler C. M., and Uhl G. R. (1994) cDNA cloning of an orphan opiate receptor gene family member and its splice variant. FEBS Lett. 348, 75-79.
48. Waters S. M., Konkoy C. S., and Davis T. P. (1995) Neuropeptide metabolism on intact, regional brain slices: effect of dopaminergic agents on substance P, cholecystokinin and Met-enkephalin degradation. J. Pharmacol. Exp. Ther. 274, 783-789.
49. Watt V. M. and Yip C. C. (1989) Aminoacid sequence deduced from rat kidney cDNA suggests it encodes the Zn-peptidase aminopeptidase N. J. Biol. Chem. 264, 5480-5487.
50. Wick M. J., Minnerath S. R., Lin X., Eide R., Law P. Y., and Loh H. H. (1994) Isolation of a novel cDNA encoding a putative membrane receptor with high homology to the cloned μ, δ and κ opioid receptors. Mol. Brain Res. 27, 37-44.
51. Xie J., Soleilhac J. M., Renwart N., Peyroux J., Roques B. P., and Fournié-Zaluski M. C. (1989) Inhibitors of the enkephalin degrading enzymes: modulation of the activity of hydroxamate containing compounds by modification of the C-terminal residue. Int. J. Pept. Protein Res. 34, 246-255.
52. Young E. A., Walker J. M., Houghten R., and Akil H. (1987) The degradation of dynorphin A in brain tissue in vivo and in vitro. Peptides 8, 701-707.
53. Zhang S. W. and Yu L. (1995) Identification of dynorphins as endogenous ligands for an opioid receptor-like orphan receptor. J. Biol. Chem. 270, 22772-22776.